Zars Pharma, Inc. - Withdrawal of Registration Statement (RW)
05 Outubro 2007 - 1:28PM
Edgar (US Regulatory)
October 5, 2007
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
|
|
|
Re:
|
|
ZARS Pharma, Inc.
Form S-1 Registration Statement
Registration File No. 333-143633
|
Ladies and Gentlemen:
Pursuant to Rules 477(a) and (b) promulgated under the Securities Act of 1933, as amended (the
Act), ZARS Pharma, Inc. (the Company) hereby requests that the Securities and Exchange
Commission consent to the withdrawal, effective as of the date hereof, of the Companys
Registration Statement on Form S-1 (File No. 333-143633) (the Registration Statement).
The Company requests withdrawal of the Registration Statement because it does not intend to conduct
the offering of shares of Common Stock contemplated thereby at this time due to market conditions.
The Registration Statement has not been declared effective and no securities have been sold in
connection with the offering.
Pursuant to Rule 477(c), the Company advises the Commission that the Company may undertake a
subsequent private offering in reliance on Rule 155(c) promulgated under the Act.
Very truly yours,
ZARS Pharma, Inc.
|
|
|
|
|
|
|
By:
|
/s/ Robert Lippert
|
|
|
Robert Lippert
|
|
|
President and Chief Executive Officer
|
|
|
|
|
|
cc:
|
|
Robert OConnor, Esq.,
Wilson Sonsini Goodrich & Rosati
Martin J. Waters, Esq.,
Wilson Sonsini Goodrich & Rosati
James Linfield, Esq.,
Cooley Godward Kronish
llp
Brent Fassett, Esq.,
Cooley Godward Kronish
llp
|
Zars Pharma (MM) (NASDAQ:ZARS)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Zars Pharma (MM) (NASDAQ:ZARS)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
Notícias em tempo-real sobre Zars Pharma (MM) da NASDAQ bolsa de valores: 0 artigos recentes
Mais Notícias de Zars Pharma, Inc.